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Abstract
Background: Malignant transformation has been reported in approximately 1% of the endometriosis cases; herein,
we report a case of clear cell endometrial carcinoma arising from endometriosis foci located within a caesarean
section scar.
Case presentation: In November 2014, a Caucasian, 44-year-old woman was transferred to our institution because
of severe respiratory failure due to massive lung embolism and rapid enlargement of a subcutaneous suprapubic
mass. Abdomino-pelvic magnetic resonance showed a 10.5 × 5.0 × 5.0 cm subcutaneous solid mass involving the
rectus abdominis muscle. Pelvic organs appeared normal, while right external iliac lymph nodes appeared enlarged
(maximum diameter = 16 mm). A whole-body positron emission tomography/computed tomography scan showed
irregular uptake of the radiotracer in the 22 cm mass of the abdominal wall, and in enlarged external iliac and inguinal
lymph nodes. In December 2014, the patient underwent exploratory laparoscopy showing normal adnexae and pelvic
organs; peritoneal as well as cervical, endometrial and vesical biopsies were negative. The patient was administered
neo-adjuvant chemotherapy with carboplatin and paclitaxel, weekly, without benefit and then underwent wide
resection of the abdominal mass, partial removal of rectus abdominis muscle and fascia, radical hysterectomy,
bilateral salpingo-oophorectomy, and inguinal and pelvic lymphadenectomy. The muscular gap was repaired
employing a gore-tex mesh while the external covering was made by a pedicled perforator fasciocutaneous
anterolateral thigh flap. Final diagnosis was clear cell endometrial adenocarcinoma arising from endometriosis
foci within the caesarean section scar. Pelvic and inguinal lymph nodes were metastatic. Tumor cells were positive for
CK7 EMA, CKAE1/AE3, CD15, CA-125, while immunoreaction for Calretinin, WT1, estrogen, and progesterone receptors,
cytokeratin 20, CD10, alpha fetoprotein, CDX2, TTF1, and thyroglobulin were all negative. Liver relapse occurred after
2 months; despite 3 cycles of pegylated liposomal doxorubicin (20 mg/m2, biweekly administration), the death of the
patient disease occurred 1 month later.
Conclusions: Attention should be focused on careful evaluation of patient history in terms of pelvic surgery, and
symptoms suggestive of endometriosis such as repeated occurrence of endometriosis nodules at CS scar, or cyclic
pain, or volume changes of the nodules.
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Background
Malignant transformation has been reported in approxi-
mately 1% of the endometriosis cases, and most fre-
quently this transformation takes place at the ovary,
accounting for about 80% of the endometriosis-associated
malignancies [1].
Endometriosis occurring in surgical abdominal scar
has been mainly documented after caesarean section
(CS) or hysterectomy (0.03 up to 0.4%), and its malig-
nant transformation is very rare [2]: clear cell histology
accounts for only 4.5% of extragonadal endometriosis-
associated malignancies, while representing the most
common histotype in case of parietal localization [1].
Given the rarity of malignant transformation of abdomi-
nal scar endometriosis to clear cell histology, pathogenesis
and risk factors of this disease are hardly assessable [3].
Nonetheless, due to the increased rate of CS registered in
the last years, we can expect a parallel increase of endo-
metriosis implants in the CS scar and occurrence of clear
cell carcinoma (CCC) of the abdominal wall.
Herein, we report a new case of CCC arising from
endometriosis foci located within a CS scar; a systematic
review of the available literature relative to this issue is
also presented.
Case presentation
In November 2014, a Caucasian, 44-year-old woman was
transferred to our institution from the emergency unit
of another hospital where she had been successfully
treated for a severe respiratory failure due to massive
lung embolism and cardiogenic shock.
Her familial history was uneventful; she had under-
gone one caesarean section 9 years before without com-
plications and had assumed oral contraceptives until the
appearance of symptoms. She had never suffered from
signs or symptoms of endometriosis.
The patient referred to have documented, since the
last 5 months, the slow enlargement of a suprapubic
mass at the CS scar (lower abdominal incision) and ab-
dominal swelling.
In July 2014, she had already performed abdomino-
pelvic magnetic resonance imaging (MRI) showing a
10.5×5.0×5.0 cm subcutaneous solid mass with cystic
areas and internal septa involving the rectus abdominis
muscle. The mass appeared strictly adherent to the
uterus and recto-sigma. Pelvic organs appeared normal,
while right external iliac lymph nodes appeared enlarged
(short axis maximum diameter = 16 mm).
The patient had been already triaged to fine needle
aspiration (FNA) of the mass which was suggestive of
endometrial tubule-papillary carcinoma.
At physical examination, a suprapubic mass of almost
20 cm maximum diameter was documented close to the
midpoint of the CS scar (Fig. 1a–c). Laboratory tests
revealed normal levels of CEA, CA125, and squamous
cell carcinoma antigen.
Once the patient recovered from the acute phase of
lung embolism and achieved haemodynamic compen-
sation, a whole-body positron emission tomography/
computed tomography (PET/CT) scan was performed
about 60 min after the intravenous administration of
18F-FDG (148 MBq), showing irregular/non-homoge-
neous uptake of the radiotracer in the 22 cm mass of
the abdominal wall. Increased 18F-FDG uptake was
also seen in enlarged external iliac and inguinal lymph
nodes bilaterally (Fig. 2b, c, e, f ). Abdomino-pelvic
MRI performed in our institution documented normal
uterus and adnexae, and confirmed the presence of the
anterior abdominal wall mass composed of solid as
well as locular areas; the mass completely infiltrated
the rectus muscle of abdomen and extended up to the
skin surface, while displacing intestinal loops. The
cleavage planes neighboring the uterus and bladder
appeared preserved as well as the inguinal, external
iliac, and obturator lymph nodes (Fig. 2a, d).
In December 2014, the patient underwent exploratory
laparoscopy showing normal adnexae and pelvic organs;
Fig. 1 Clinical appearance of the patient at time of presentation (a–c): a
large mass (a, b) extended from the pubic symphysis to the umbilicus
was evident; the mass appeared mainly solid with some cystic lesions
on the surface. The caesarean section scar is evident (white arrow).
Appearance of the abdominal reconstruction after 2 months from
surgery (d)
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peritoneal as well as cervical, endometrial, and vesical
biopsies were negative.
Considering the results of FNA suggesting primary
Müllerian-derived carcinoma and the extent of disease
whose radical resection would require widely demolitive
surgical procedures, the patient was triaged to neo-
adjuvant chemotherapy with carboplatin (AUC = 2), and
paclitaxel (80 mg/m2), every week. After 3 cycles (9 ad-
ministrations) MRI documented only a slight reduction
of the mass and lymphadenopathies, thus leading to
consider the need of a multidisciplinary approach with
gynecologic and medical oncologists, surgeons, and plas-
tic surgeons in order to plan the most adequate patient
treatment. After a thorough evaluation, radical surgery
with reconstruction was planned, and an extensive coun-
seling was carried out with the patient and her relatives.
At the beginning of March 2015, the patient under-
went wide resection of the abdominal mass, partial re-
moval of rectus abdominis muscle and fascia; moreover,
radical hysterectomy, bilateral salpingo-oophorectomy
(BSO) as well as inguinal and pelvic lymphadenectomy
were performed.
At the end of surgery, the abdominal wall defect ap-
peared as a round hole of 14 × 14 cm which involved the
abdominal wall thickness completely. The muscular gap
was repaired employing a gore-tex mesh anchored directly
on the residual rectus muscles and sheets. The external
covering had been planned by a pedicled perforator fascio-
cutaneous anterolateral thigh flap. The perforator vessels
from the descending branch of the lateral circumflex
femoral artery had been preoperatively located, with ultra-
sound doppler sonography, at the level of the intermuscu-
lar lateral septum of the thigh. The right thigh was chosen
as donor site because the perforators were more distal,
thus allowing to lengthen the pedicle. The donor site, on
the right thigh, was repaired both by direct closure, and a
skin graft harvested from the contralateral thigh. Postope-
rative course of the wounds was uneventful and stitches
were removed at 2 weeks. The patient was discharged
after 18 days in good clinical conditions, and the cosmetic
result was acceptable (Fig. 1d).
Macroscopically, the surgical specimen consisted of
cutis and subcutaneous tissue which contained a capsu-
lated tumor mass measuring 18 cm in maximum diame-
ter, infiltrating the rectus abdominis muscle. The cut
surface was whitish and showed areas of necrosis and
hemorrhage. Histological examination of tissue samples
revealed neoplastic proliferation of large-sized, epithelio-
morphous cells with abundant clear or occasionally eosino-
philic cytoplasm and prominent nucleoli. A remarkable
degree of nuclear atypia with diffuse hyperchromasia and
irregular nuclear contours, and cellular pleomorphism was
evident throughout the whole lesion. Architecturally, the
tumor featured a mixed pattern of growth, both solid and
tubulocystic, occasionally including distinctive papillary
areas with hyalinized stromal cores. The clear cells lining
the papillae and the cystic spaces showed the characteristic
hobnail appearance. A few eosinophilic hyaline globules
were observed as well (Fig. 3a–c). Interestingly, sparse foci
of endometriosis were present in the fibrous adipose tissue
all around. Surgical margins were free of disease.
Immunohistochemical investigation showed positive
tumor cell reaction for CK7 (Fig. 3d), EMA, CKAE1/
AE3, CD15, CA-125. On the contrary, immunoreaction
for Calretinin, WT1, estrogen, and progesterone recep-
tors, cytokeratin 20, CD10, alpha fetoprotein, CDX2,
TTF1, and thyroglobulin were all negative. Hence, the
morphologic findings and the immunohistochemical re-
sults were consistent with a diagnosis of clear cell
adenocarcinoma most likely arising in the setting of an
a b c
d e f
Fig. 2 Pre-surgical T2-weighted FSE sagittal MRI (a) documenting a
supra-vesical pelvic mass extending into the anterior pelvic wall and
showing non-homogeneous signal intensity and solid components.
Sagittal CT (b) and fused 18F-FDG PET/CT (c) images showed non-
homogeneous uptake in the 22 cm abdominal mass: in particular,
intense abnormal 18F-FDG uptake was present in the caudal solid
component of the mass, whereas an absent area of tracer uptake
was evident in its cranial fluid component. Corresponding T2-weighted
FSE axial MRI (d) confirmed the presence of a solid and partially fluid
pelvic mass, and enlarged loco-regional lymph nodes (arrow). Axial CT
(e) and fused 18F-FDG PET/CT images (f) showed intense tracer uptake
in the solid component of the mass, extended up to the skin surface
of pelvis, and enlarged left external iliac lymph-node, characterized by
increased tracer uptake (arrows)
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abdominal wall endometriosis. Lymph node involvement
was documented in 7 out of 14 pelvic lymph nodes, and
in 8 out of 11 inguinal lymph nodes.
After 2 months from surgery, the patient was submit-
ted to total body CT scan in order to plan subsequent
adjuvant treatment. Despite the absence of disease in the
pelvis, CT scan documented the appearance of six neo-
plastic lesions (from 2.7 to 5.5 cm maximum diameter)
in the liver. Treatment with pegylated liposomal doxo-
rubicin (20 mg/m2, biweekly administration) was started,
and CT scan evaluation after 3 cycles showed the pro-
gression of hepatic involvement and appearance of asci-
tes. The death of the patient disease occurred 1 month
later.
Discussion
We have provided an additional patient to the series of
22 cases of endometriosis-associated CCC arising within
CS scar, as reported in the literature [4–24]. Only 2 re-
ports were not available from the requested authors.
Despite the rarity of this condition, the number of re-
ported cases has increased over time (see Table 1) likely
due to a higher attention focused on this disease, but
also to the increased rate of CS and uterine surgeries
documented over time. Therefore, more diffuse aware-
ness of this condition and better understanding of its
pathogenesis could be important to provide early diag-
nosis and more effective treatment.
Even though the criteria for the diagnosis of
endometriosis-associated malignancies include also the
coexistence of neoplastic endometrial tissue and endo-
metriosis, almost one third of CCC arising within CS
scars were not associated with endometriosis foci (Table 1).
However, it has to be considered that four patients had re-
ferred cyclic pain in the CS scar during menses, or the
cyclic increase/decrease of the mass volume, which could
be highly suggestive of the presence of endometriosis
implants [14, 17, 19, 23]. Moreover, previous history of the
excision of benign endometriosis foci at the CS scar was
reported in five cases [9, 11, 13, 15, 16]. Therefore, the ab-
sence of pathologically assessed endometriosis foci could
be interpreted as either a sampling problem or a conse-
quence of the complete replacement of normal tissue due
to massive neoplastic proliferation. In this context,
careful collection and evaluation of patient history
would be important to have a high index of suspicion
for endometriosis-associated malignancy.
Indeed, these masses usually reach very large dimen-
sions (median diameter: 9 cm, range 2.5 up to 22 cm)
(Table 1) before the diagnosis is made, thus highlighting
the difficulties to suspect this condition and obtain an
early diagnosis. This is clinically relevant since primary
surgical treatment very frequently requires wide surgical
excision of the mass together with partial removal of
part of the abdominal muscles and reconstructive sur-
geries with a mesh or even pedicle-skin-muscle flap.
Demolitive surgery was also necessary in the 3 cases ini-
tially triaged to neo-adjuvant chemotherapy ([13, 18]
current case), since only 1 of them achieved partial re-
sponse after 8 cycles of carboplatin/paclitaxel chemo-
therapy [18]; in addition, wide excision was necessary in
the 2 cases who had undergone excision of endometriosis
nodules at the CS scar in the past, and had been unsuc-
cessfully treated with GnRh and progestins, respectively,
before being triaged to radical surgery which led to defini-
tive diagnosis of malignancy. Besides wide resection of the
mass, other surgical procedures were often carried out
including BSO (82.6%), as well as hysterectomy (71.4%),
or endometrial biopsy (9.5%, and omentectomy or omen-
tal biopsy (30.4%), in order to exclude other primary
tumors sites.
Despite the aggressiveness of surgery and the multi-
modal treatment approach, of 18 cases with available
follow up data, 10 experienced relapse of disease, mostly
at distant sites, and 8 patients died of disease.
Apart from the long time interval to diagnosis and
the wide extension of disease in the abdominal wall,
Fig. 3 The tumor displayed a mixed pattern of both tubulocystic
and papillary growth, HE x5 (a), and HEx10 (b); cells were large with
abundant clear or occasionally eosinophilic cytoplasm. Note the
high-grade nuclear atypia, HEx20 (c); neoplastic cells showed positive
cell membrane immunostaining for CK7 (x20) (d)
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40 1 CS 15 years before – – – WE, BSO, Hys Mass: CCC + endometriosis
Ovaries and uterus:
negative
RT, progestins – Yes after
18 months
Hitti, 1996 [5] 46 1 CS 14 years before
1 CS 12 years before




Miller 1998 [6] 38 1 hysterotomy 9 years
before
1 abortion 3 years
before
1 CS 2 years before













Park 1999 [7] 56 1 CS 24 years
1 CS 20 years
– 5 – WE Mass: CCC + endometriosis RT – –
Ishida 2003 [8] 56 1 CS 24 years
1 CS 20 years







Sergent 2006 [9] 45 1 CS 25 years
1 CS 23 years
2 excisions of benign
endometriosis nodules
at the scar
17 20 – WE, BSO,
later on: endometrial
curettage




Margins: 1 cm free




Alberto 2006 [10] 38 1 CS 11 years
BSO, Hys for
endometriosis
6 6 – WE CCC Carbo/PTX
RT
– –
Razzouk 2007 [11] 46 1 CS 26 years before




– >20 – GnRh analogue without
benefit WE, BSO
Mass: CCC + endometriosis
Ovaries: negative
LN: 1 positive
Carbo/PTX Yes during CT Yes after
6 monthsb
Rust 2008 [12] 42 3 CS
Hys 5 years before
24 5 Carcinoma WE Mass: CCC + endometriosis
Margins: 1 mm free
Not done – –




– 10 Atypical cells NACT (carbo/PTX)
No benefit WE, BSO,
Hys, omentectomy




Margins: 2 mm free
Not done Yes after 4 monthsa –
Williams 2009 [14] 53 1 CS 17 years before 24 2.5 CCC (excisional
biopsy)







Inguinal LN: 7 positive/11
Pelvic LN: 8 positive/14
Carbo/PTX
(4 cycles)
Yes after 3 monthsa Yes after
11 monthsb
Bourdel 2010 [15] 43 1 CS 20 years before
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Mass: CCC + endometriosis



















Table 1 Clear cell carcinoma arising from endometriosis of the scar caesarean section (Continued)
Yan 2011 [16] 41 2 CS 5 years before
2 excisions of benign
endometriosic nodule
at the scar 1 year and
4 months before
4 9 Not done Progestins without
benefit WE








Noc after 8 months Noc after
8 months
Mert 2012 [19] 42 Tubal ligation, right
ovariectomy
– 15 Tumor cells
Mullerian origin
NACT (carbo/PTX)
WE, left SO Hys,
left Pelvic LNctomy
Omentectomy
Mass: CCC + endometriosis
Other organs: negative
Margins: free




12 6 Excisional biopsy
CCC + endometriosis










Mass: CCC + endometriosis
Ovarian cyst: endometriosis
Endometrium: negative





Yes after 5 monthsb No after
7 monthsb
Ijichi 2014 [20] 60 1 CS 37 years before
1 CS 35 years before
48 4 Atypical cells WE Mass: CCC + endometriosis
Margins: free
Not done Yes after 8 monthsa No after
23 monthsa
Aust 2015 [21] 47 1 CS 16 years before
vaginal Hys 10 years
before














Heller 2014 [22] 37 1 CS
1 CS
1 CS 8 years before




LFN: multiple LN positive
Refused
treatment
Yes after 5 monthsa –












Pelvic LN: 18 positive/21
Aortic LN: 6 positive /6







Sosa-Duràn 2015 [24] 45 1 CS
1 CS
1 CS




Current case 44 1 CS 9 years before 8 22 Endometrial carcinoma NACT (carbo/PTX)
WE, BSO, Hys, inguinal,
and pelvic LNctomy
Mass: CCC + endometriosis
Ovaries, uterus: negative
Pelvic LN: 7 positive/14
Inguinal LN: 8 positive/11
Margins: free




CCC clear cell carcinoma, CS caesarean section, WE wide mass excision, BSO bilateral salpingo-oophorectomy, SO salpingo-oophorectomy, Hys hysterectomy, LNctomy lymphadenectomy, LN lymph node, Carbo carboplatin,
CIS cisplatin, PTX paclitaxel, RT radiotherapy
*The mass was reported to have come and gone over the last 8 years since the last CS
aFrom surgical resection
bFrom initial diagnosis














clinical aggressiveness is also sustained by the intrinsic
biologic aggressiveness of CCC, which differs from
other endometrial cancer histotypes. In this context,
proper diagnosis should take advantage of immunohis-
tochemical panels with several markers in order to ex-
clude serous histotype as well as mesothelial tumors
such as malignant mesothelioma and papillary meso-
thelioma which are usually positive for Calretinin,
WT1, and keratin 5/6, contrary to what is observed in
CCC. In addition, WT1 is the most important immuno-
histochemical marker to distinguish serous carcinoma
from CCC.
It has to be acknowledged that of 9 cases undergoing
lymphadenectomy or sampling, 8 showed diffuse meta-
static involvement of inguinal, and/or pelvic, and/or aor-
tic lymph nodes ([11, 14, 15, 19, 22, 23] current case).
On the other hand, some cases were reported to ex-
perience relatively longer disease-free and overall sur-
vival (≥30 months) [5, 6, 16, 18]; while recognizing that
a more thorough molecular characterization could hope-
fully help define prognosis of this very rare condition, it
has to be acknowledged that cases with better outcome
presented with masses ranging between 4 and 9 cm, thus
suggesting that a prompt recognition and treatment
could make the difference.
Obviously, also prevention of endometriosis implant-
ation at time of CS is of utmost importance: as recently
emphasized, the uterus should not be exteriorized, ex-
posure of endometrial mucosa during uterus suturing
should be limited, and peritonization may be advised, al-
though there is no definitive data about these issues [15].
Conclusions
Attention should be focused on careful evaluation of pa-
tient history in terms of pelvic surgery, and symptoms
suggestive of endometriosis such as repeated occurrence
of endometriosis nodules at CS scar, or cyclic pain, or
volume changes of the nodules.
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